ARGOS THERAPEUTICS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$99.2M

222 transactions

Summary

ARGOS THERAPEUTICS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $19.8MSales: $203K25 insiders

Date	Insider	Type	Value
2018-01-10	Abbey Jeffrey D(President, CEO)	Sell	$20K
2018-01-09	Abbey Jeffrey D(President, CEO)	Sell	$20K
2018-01-03	Abbey Jeffrey D(President, CEO)	Sell	$18K
2018-01-03	Abbey Jeffrey D(President, CEO)	Sell	$18K
2018-01-10	Katz Richard D(Vice President and CFO)	Sell	$17K
2018-01-09	Katz Richard D(Vice President and CFO)	Sell	$17K
2018-01-03	Katz Richard D(Vice President and CFO)	Sell	$16K
2018-01-10	Nicolette Charles A.(CSO and Vice President of R&D)	Sell	$16K
2018-01-09	Nicolette Charles A.(CSO and Vice President of R&D)	Sell	$16K
2018-01-10	Harrelson Lori R.(Vice President of Finance)	Sell	$10K
2018-01-09	Harrelson Lori R.(Vice President of Finance)	Sell	$10K
2018-01-03	Harrelson Lori R.(Vice President of Finance)	Sell	$9K
2018-04-25	Nicolette Charles A.(CSO and Vice President of R&D)	D	$0
2018-04-25	Harrelson Lori R.(Vice President of Finance)	D	$0
2018-04-25	Katz Richard D(Vice President and CFO)	D	$0
2018-04-25	Abbey Jeffrey D(Chief Executive Officer)	D	$0
2018-03-28	Abbey Jeffrey D(Chief Executive Officer)	A	$0
2018-03-28	Nicolette Charles A.(CSO and Vice President of R&D)	A	$0
2018-03-28	Harrelson Lori R.(Vice President of Finance)	A	$0
2018-03-28	Katz Richard D(Vice President and CFO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ARGOS THERAPEUTICS INC — Contributions, Lobbying & Contracts | Poliscope